Supplementary Figure 2: miR-122 inhibits in vivofeatures of allergic inflammation. (A) RBL2H3 cells were transfected with
the indicated inhibitor along with scrambled siRNA or SOCS1 (each 10 nM). Immunoprecipitation and western blot were performed. (B) Same as (A) except that qRT-PCR analysis was performed. **, p<0.005. (C) Same as (B) except that β-hexosamindase activity assays were performed. *, p<0.05. (D) BALB/c mice were given an intravenous injection of scrambled (100 nM) or SOCS1 siRNA (100 nM) along with the indicated inhibitor (each at 100 nM)). The next day, BALB/c mice were given an intravenous injection of 2% (v/v) Evans blue solution. ***, p<0.0005. (E) Ear tissue lysates from BALB/c mouse of each experimental group were subjected to qRT-PCR analysis and β-hexosaminidase activity assay. **, p<0.005. (F) Ear tissue lysates from BALB/c mouse of each experimental group were subjected to western blot and immunoprecipitation. ). BALB/C mice were given an intravenous injection with scrambled siRNA (100 nM) or SiSOCS1 RNA (100 nM) on days 7, 10, 14, 17, 21and 23 of the time line. (B) Tumor tissue lysates were subjected to β-hexosaminidase activity assays and qRT-PCR analysis. ***, p<0.0005. (C) Tumor tissue lysates from each experimental group were subjected to western blot and immunoprecipitation.
